Showing results (131-140 of 175) with videos related to
Sort By:
Pageof 18
American Journal of Clinical Oncology|June 1, 1984
Phase II trial of cisplatin as second-line chemotherapy in patients with advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group studyJ T Thigpen, J A Blessing, L D Lagasse, et al.The New England Journal of Medicine|December 2, 1982
Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trialsM H Greene, J D Boice, B E Greer, et al.Gynecologic Oncology|October 1, 1996
A phase II trial of prolonged oral etoposide (VP-16) as second-line therapy for advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group studyP G Rose, J A Blessing, G S Lewandowski, et al.American Journal of Clinical Oncology|December 1, 1992
5-fluorouracil and low-dose leucovorin in the treatment of recurrent squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology GroupK Y Look, J A Blessing, H B Muss, et al.Gynecologic Oncology|October 29, 1998
A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group studyK Y Look, J A Blessing, C Levenback, et al.Gynecologic Oncology|January 1, 1986
Phase II trial of cisplatin in advanced or recurrent cancer of the vagina: a Gynecologic Oncology Group StudyJ T Thigpen, J A Blessing, H D Homesley, et al.American Journal of Clinical Oncology|April 1, 1984
ICRF-159 (razoxane) in patients with advanced squamous cell carcinoma of the uterine cervix. For the Gynecologic Oncology GroupJ F Conroy, G C Lewis, J A Blessing, et al.Gynecologic Oncology|April 1, 1996
Combination chemotherapy with hydroxyurea, dacarbazine (DTIC), and etoposide in the treatment of uterine leiomyosarcoma: a Gynecologic Oncology Group studyJ Currie, J A Blessing, H B Muss, et al.American Journal of Clinical Oncology|December 1, 1993
A Gynecologic Oncology Group phase II study of amonafide (NSC 308847) in epithelial ovarian cancerR F Asbury, J A Blessing, K Y Look, et al.American Journal of Clinical Oncology|August 1, 1990
Echinomycin (NSC 526417) in advanced ovarian cancer. A phase II trial of the Gynecologic Oncology GroupH B Muss, J A Blessing, V V Baker, et al.Pageof 18